SiteOne Landscape Supply, Inc. (NYSE:SITE) Q3 2024 Earnings Call Transcript
SiteOne Landscape Supply, Inc. (NYSE:SITE) Q3 2024 Earnings Call Transcript October 30, 2024SiteOne Landscape Supply, Inc. misses on earnings expectations.
Siteone Landscape Supply Inc. (SITE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Impax Asset Management Ian Simm | 1,040,908 | $157,083,426 | 0.61% | |
| 2. | Southpoint Capital Advisors John Smith Clark | 500,000 | $75,455,000 | 1.78% | |
| 3. | Impactive Capital Lauren Taylor Wolfe | 457,161 | $68,990,167 | 2.56% | |
| 4. | Balyasny Asset Management Dmitry Balyasny | 188,571 | $28,457,250 | 0.04% | |
| 5. | Citadel Investment Group Ken Griffin | 163,596 | $24,688,273 | -16% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.31 | 718 | Director | 2,596 | 2018-02-28 | Filing | |
| $50.76 | 6,200 | Officer, Director | 400,743 | 2017-05-25 | Filing | |
| $32.80 | 15,000 | Officer, Director | 394,543 | 2016-12-06 | Filing | |
| $21.00 | 5,000 | Director | 5,000 | 2016-05-17 | Filing | |
| $21.00 | 1,150 | Officer | 5,216 | 2016-05-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $142.20 | 6,500 | Officer | 12,942 | 2024-11-21 | Filing | |
| $129.04 | 878 | Director | 11,267 | 2024-08-05 | Filing | |
| $160.01 | 10,000 | Officer, Director | 578,361 | 2024-05-15 | Filing | |
| $162.10 | 10,000 | Officer, Director | 574,657 | 2024-04-17 | Filing | |
| $176.35 | 10,000 | Officer, Director | 574,657 | 2024-03-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,134,723 | $671,892,487 | 0.01% | |
| 2. | 4,035,047 | $655,695,141 | 0.01% | |
| 3. | 3,384,314 | $549,951,026 | 1.37% | |
| 4. | 2,126,087 | $345,489,137 | 0.28% | |
| 5. | 1,495,341 | $242,992,912 | 0.64% |
News See All
Here’s Why SiteOne Landscape Supply (SITE) Declined in Q2
Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s Why Siteone Landscape Supply (SITE) Traded Lower in Q2
Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
SiteOne Landscape Supply (SITE) Slid as Pricing And Margins Fell Short Of Expectations
Conestoga Capital Advisors, an asset management company, released its “Small Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Is SiteOne Landscape Supply (SITE) an Undervalued Stock Now?
Baron Funds, an investment management company, released its “Baron Small Cap Fund” second-quarter 2024 investor letter. A copy can be downloaded here.
SiteOne Landscape Supply, Inc. (NYSE:SITE) Q2 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the SiteOne Landscape Supply Second Quarter 2024 Earnings Call. [Operator Instructions]. As a reminder, this conference is being recorded.
SiteOne Landscape Supply, Inc. (NYSE:SITE) Q1 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the SiteOne Landscape Supply First Quarter 2024 Earnings Call. All participants will be in listen-only mode.
Here’s Why SiteOne Landscape Supply (SITE) Sold Off in Q4
Conestoga Capital Advisors, an asset management company, released its “SMid Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
SiteOne Landscape Supply, Inc. (NYSE:SITE) Q4 2023 Earnings Call Transcript
SiteOne Landscape Supply, Inc. beats earnings expectations. Reported EPS is $-0.08, expectations were $-0.18. SiteOne Landscape Supply, Inc.
Analysts on Wall Street Lower Ratings for These 5 Stocks
On December 19, Morgan Stanley analyst Jeffrey Hung downgraded PTC Therapeutics, Inc. (NASDAQ:PTCT) from Equalweight to Underweight, within the biotechnology industry.